U.S. Markets close in 5 hrs 25 mins

Pfizer Inc. (PFE)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
33.359-0.001 (-0.003%)
As of 10:35AM EDT. Market open.
People also watch
Full screen
Previous Close33.360
Bid33.280 x 1100
Ask33.290 x 8900
Day's Range33.250 - 33.450
52 Week Range29.830 - 35.380
Avg. Volume18,956,709
Market Cap199.08B
PE Ratio (TTM)28.08
Earnings DateN/A
Dividend & Yield1.28 (3.84%)
Ex-Dividend Date2017-08-02
1y Target EstN/A
Trade prices are not sourced from all markets
  • Market Realist3 hours ago

    How Amgen’s Nephrology Drugs Are Positioned after 2Q17?

    In 2Q17, Amgen’s (AMGN) Aranesp generated revenues of ~$535 million, which represented a 6% year-over-year rise.

  • The Bull Case for Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Weak

    The Bull Case for Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Weak

    Giving credit where credit is due, I do think Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock looks stronger than it did just a couple of quarters ago. VRX stock has still declined 1.5% so far this year, but the narrative surrounding the company has certainly changed. On the Q2 conference call, Valeant management made a big deal of the fact that 73% of Q2 revenue came from Bausch & Lomb and the Salix business.

  • Market Realist2 days ago

    Pfizer’s Corporate and Pipeline Developments in 2Q17

    Apart from Pfizer’s (PFE) product developments, let's take a look at some recent pipeline and corporate developments.